Development and content validity of the Functional Impacts of Narcolepsy Instrument: a novel patient-reported outcome measure for narcolepsy type 1 and type 2. [PDF]
Savva Y +8 more
europepmc +1 more source
Rapid Eye Movement (REM)-Predominant Obstructive Sleep Apnea (OSA) Coexisting With and Initially Obscuring Narcolepsy Type 1: A Nine-Year Longitudinal Case Report. [PDF]
Bouhamdi A +11 more
europepmc +1 more source
Development of Narcolepsy Type 1 Following COVID-19 Infection in a Patient Previously Diagnosed With Idiopathic Hypersomnia: A Case Report. [PDF]
Pham B, Memon T.
europepmc +1 more source
Cytokines in narcolepsy type 1: pathogenic relevance, biomarker potential, and future directions. [PDF]
Gao J, Jia L, Qu Z, Wang X.
europepmc +1 more source
A historical overview of the cardiovascular safety of sodium oxybate: clinical trials, clinical experience. [PDF]
Kushida CA.
europepmc +1 more source
Immunocyte phenotypes underlying the causal autoimmune features in narcolepsy type 1. [PDF]
Li T +10 more
europepmc +1 more source
Reply to "The question of whether narcolepsy increases mortality should be answered based on reliable studies". [PDF]
Sharafkhaneh A +8 more
europepmc +1 more source
Reply to "Unexpectedly higher mortality in non‑type 1 narcolepsy: diagnostic heterogeneity or unmeasured confounders?" [PDF]
Sharafkhaneh A +8 more
europepmc +1 more source

